# Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.

> clinical trial · VERIFIED · 2026-08-20

Status: RECRUITING · Sponsor: MedSIR · Condition: Advanced Breast Cancer

- Company: MedSIR
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06382948

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.